Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (291-300 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|July 3, 2025
Perioperative pembrolizumab demonstrates clinical benefit in locally advanced HNSCCDavid Killock
Nature Reviews. Clinical Oncology|August 28, 2021
MajesTEC results with teclistamab in RRMMDavid Killock
Nature Reviews. Clinical Oncology|May 31, 2020
ICI for resected stage IV melanomaDavid Killock
Nature Reviews. Clinical Oncology|April 18, 2020
Viral gene therapy active in ovarian cancerDavid Killock
Nature Reviews. Clinical Oncology|June 11, 2020
From the ASCO20 Virtual meetingDavid Killock
Nature Reviews. Clinical Oncology|March 3, 2026
Lisocabtagene maraleucel has high efficacy in R/R MZLDavid Killock
Nature Reviews. Clinical Oncology|May 14, 2026
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancerDavid Killock
Nature Reviews. Clinical Oncology|June 12, 2026
Potential new standard of care for resectable gastro-oesophageal adenocarcinoma in AsiaDavid Killock
Nature Reviews. Clinical Oncology|August 20, 2016
Beware trial end point comparisonsDavid Killock, Lisa Hutchinson
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2010
Monitoring RhoGTPase activity in lymphocytesMarouan Zarrouk, David Killock, Aleksandar Ivetic
Pageof 31

Showing results (291-300 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|July 3, 2025
Perioperative pembrolizumab demonstrates clinical benefit in locally advanced HNSCCDavid Killock
Nature Reviews. Clinical Oncology|August 28, 2021
MajesTEC results with teclistamab in RRMMDavid Killock
Nature Reviews. Clinical Oncology|May 31, 2020
ICI for resected stage IV melanomaDavid Killock
Nature Reviews. Clinical Oncology|April 18, 2020
Viral gene therapy active in ovarian cancerDavid Killock
Nature Reviews. Clinical Oncology|June 11, 2020
From the ASCO20 Virtual meetingDavid Killock
Nature Reviews. Clinical Oncology|March 3, 2026
Lisocabtagene maraleucel has high efficacy in R/R MZLDavid Killock
Nature Reviews. Clinical Oncology|May 14, 2026
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancerDavid Killock
Nature Reviews. Clinical Oncology|June 12, 2026
Potential new standard of care for resectable gastro-oesophageal adenocarcinoma in AsiaDavid Killock
Nature Reviews. Clinical Oncology|August 20, 2016
Beware trial end point comparisonsDavid Killock, Lisa Hutchinson
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2010
Monitoring RhoGTPase activity in lymphocytesMarouan Zarrouk, David Killock, Aleksandar Ivetic
Pageof 31